Company / Profit Margin
Corbus Pharmaceuticals Holdings, Inc. Profit Margin History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-5176.4%
FY2022
5-year range
-5176.4% / -197.7%
FY2018-FY2022
Trend
-83.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -197.7% to -5176.4% over the past 2 years.
Based on SEC 10-K filings.
-5176.4% in FY2022 with a 5-year CAGR of -3811.3%.
Declined from -197.7% to -5176.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -4021.9pp
- 5-Year Change
- -3811.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, profit margin decreased 83.2% year-over-year.
- Peak profit margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -5176.4% | -83.2% |
| FY2021 | -2826.1% | -1329.6% |
| FY2020 | -197.7% | +82.9% |
| FY2019 | -1154.5% | +13.1% |
| FY2018 | -1328.7% | +2.7% |
| FY2017 | -1365.0% | +0.0% |
| FY2016 | -1365.0% | -248.4% |
| FY2015 | -391.8% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026